Researchers, oncologists, pulmonologists, thoracic surgeons, and patients convene at the World Conference on Lung Cancer (WCLC) each year to discuss developments impacting the lung cancer community.  

This year the International Association for the Study of Lung Cancer (IASLC)’s World Conference on Lung Cancer celebrates its 50-year anniversary in San Diego, CA, on September 7-10. There, the GO2 for Lung Cancer team will be sharing a record number of posters and presentations on the following topics: 

Global perspectives  

  • Availability of supportive care in lung cancer: A global perspective (Session: EP.16F.02)  
  • 15 years of the Lung Cancer Living Room: Expert speaker series provides critical education to global audience (Session: EP.16E.02)  
  • Lung cancer patients’ support preferences: Insights from a global patient experience survey (Session: P2.16E.01)  
  • Lung cancer patients’ preferred methods of involvement with their treatment teams: Insights from a global patient experience survey (Session: EP.16F.03) 
  • Lung cancer patients’ preferred methods of receiving information from their treatment teams: Insights from a global patient experience survey (Session: EP.16B.02)  
  • Patient experiences of biomarker testing: Insights from a global patient experience survey (Session: EP.16A.01) 

Whole person care 

  • What should be available to ensure the emotional needs of people affected by lung cancer are met? (Session: ES.03.03) 
  • Advanced cancer survivorship (Session: ES38) 
  • Latest advances in unresectable local-regional NSCLC-smoking cessation improves health outcomes (Session: ES43) 
  • Successful implementation of a Lung Cancer Navigator Workshop: A cancer site-specific training program by GO2 for Lung Cancer (Session: P4.15C.03) 
  • Characterization of the basic financial needs of those living with lung cancer (Session: MA10.05) 
  • Emotional support resource access and utilization among people with lung cancer (Session: P2.16E.02) 

Precision medicine 

  • Role of diet and exercise in young lung cancer patients with driver mutations (NCT04640259) (Session: EP.01A.01) 
  • The INHERIT Study – INvestigating HEreditary Risk In Thoracic Cancers (NCT05587439) (Session: P1.01A.01) 

Lung cancer health equity 

  • Development of a framework to address lung cancer health disparities: One organization’s experience (Session: P2.16C.02) 
  • Awareness, stigma, and fatalism towards cancer clinical trials among Black individuals diagnosed with lung cancer (Sessions: P2.16C.01 and PT02.16.04) 
  • Ready, set, screen: Evaluating community readiness for lung cancer screening among non-Hispanic Black populations in Florida (Session: EP.16G.01) 
  • A framework and toolkit to support the implementation of LDCT screening with a focus on inclusion of underserved communities (Session: EP.04A07) 

We look forward to seeing you at WCLC and sharing key takeaways for the lung cancer community when we return from sunny San Diego.